Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes

Blood

Volumn 89, Issue 7, 1997, Pages 2259-2267

  Bauer, Gerhard ^b   Valdez, Penelope ^b   Kearns, Karen ^b   Bahner, Ingrid ^b   Wen, Sui Fang ^b   Zaia, John A ^b   Kohn, Donald B ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CD34 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR; VIRUS VECTOR;

ARTICLE; CELL GROWTH; CELL ISOLATION; COLONY FORMATION; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RETROVIRUS; VIRUS INHIBITION;

EID: 0030935630     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.7.2259     Document Type: Article

References (22)

1. Gilboa E, Smith C: Gene therapy for infectious diseases: The AIDS model. Trends Genet 10:139, 1994
2. Pomerantz RJ, Trono D: Genetic therapies for HIV-1-intections: Promise for the future. AIDS 9:985, 1995
3. + hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture. J Virol 70:4352, 1996
4. Zhou C, Bahner IC, Larson GP, Zaia JA, Rossi JJ, Kohn DB: Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Gene 149:33, 1994
5. Zhou C, Bahner I, Rossi JJ, Kohn DB: Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibition. Antisense Res Dev 6:17, 1996
6. Bahner I, Zhou C, Yu XJ, Hao QL, Guatelli JC, Kohn DB: Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes. J Virol 67:3199, 1993
7. Malim MH, Bohnlein S, Hauber J, Cullen BR: Functional dissection of the HIV-1 rev trans-activator - Derivation of a transdominant repressor of rev function. Cell 58:205, 1989
8. Koyanagi Y, Miles S, Mitsuya RT, Merrill JE, Vinters HV, Chen ISY: Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819, 1987
9. Miller AD, Buttimore C: Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6:2895, 1986
10. Collins LS, Dorshkind K: A stromal cell line from myeloid long term bone marrow cultures can support myelopoiesis and B lymphopoiesis. J Immunol 138:1082, 1987
11. Miller AD, Rosman GJ: Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980, 1989
12. Miller AD, Trauber DR, Buttimore C: Factors involved in production of helper-free retrovirus vectors. Somatic Cell Mol Genet 12:175, 1986
13. Morgan RA, Cornetta K, Anderson WF: Application of the polymerase chain reaction in retroviral mediated gene transfer and the analysis of gene marked human TIL cells. Hum Gene Ther 1:135, 1990
14. Nolta JA, Smogorzewska EM, Kohn DB: Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 86:101, 1995
15. Nolta JA, Kohn DB: Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum Gene Ther 1:257, 1990
16. Kearns K, Bahner I, Bauer G, Wen SF, Valdez P, Wheeler S, Woods L, Miller R, Casciato D, Galpin J, Church J, Kohn DB: Suitability of bone marrow from HIV-1 infected donors for retroviral-mediated gene transfer. Hum Gene Ther 8:301, 1997
17. Schwartz GN, Kessler SW, Rothwell SW, Burrell LM, Reid TJ, Meltzer MS, Wright DG: Inhibitory effects of HIV-1 infected stromal cell layers on the production of myeloid progenitor cells in human long-term bone marrow cultures. Exp Hematol 22:128, 1994
18. Bordignon C, Notarangelo LD, Nobili N, Ferrari G, Casorati G, Panina P, Mazzolari E, Maggioni D, Rossi C, Servida P, Ugazio AG, Mavilio F: Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270:470, 1995
19. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santanta VM, Anderson WF, Ihle JN: Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134, 1993
20. Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, Doren S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt AJ, Stewart FM, Leitman SF, Wilson WH, Cowan K, Young NS, Nienhuis AW: Retrovirally marked CD34-enriched peripheral blood bone marrow cells contribute to long term engraftment after autologous transplantation. Blood 85:3048, 1995
21. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, El-Khoureiy A, Lawrence K, Wells S, Moen RC, Bastian J, Williams-Herman DE, Elder M, Wara D, Bowen T, Hershfield MS, Mullen CA, Blaese RM, Parkman R: Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med 1:1017, 1995
22. Kohn DB, Weinberg KI, Lenarsky C, Crooks GM, Heiss LN, Nolta JA, Smogorzewska EM, Bastian J, Wara D, Elder M, Bowen T, Hershfield M, Blaese RM, Parkman R: Selective accumulation of ADA gene-transduced T-lymphocytes upon PEG-ADA dosage reduction after gene therapy with transduced CD34+ umbilical cord blood cells. Blood 86:1168a, 1995 (abstr, suppl 1)